FDA/AHRQ collaboration
Executive Summary
ODS Deputy Director Anne Trontell will embark on a year-long FDA-sponsored detail beginning in mid-January as a senior advisor in pharmaceutical outcomes research for the Agency for Healthcare Research & Quality. The move will help to improve understanding of the health outcomes of marketed drugs, FDA says, noting the collaboration is part of an effort to foster research partnerships on drug effectiveness and safety. Trontell will promote collaborative research between FDA, AHRQ, CMS, and professional and academic institutions. Office of Pharmacoepidemiology and Statistical Science Deputy Director Jonca Bull will serve as acting ODS deputy director...